2006
DOI: 10.1002/cbf.1284
|View full text |Cite
|
Sign up to set email alerts
|

Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas

Abstract: The purpose of this study was to demonstrate the relationship between serum PON1 activity and PON 192 polymorphism in brain tumours. The distribution of PON 192 polymorphism in 42 high grade gliomas and 42 meningiomas were determined by polymerase chain reaction--based restriction fragment length polymorphism analysis and compared with 50 healthy control subjects. Serum paraoxonase1 activities were also measured and compared in the same population. We found that in both tumour groups serum PON1 activity was si… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
17
0
2

Year Published

2008
2008
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(21 citation statements)
references
References 22 publications
(28 reference statements)
2
17
0
2
Order By: Relevance
“…Our review indicated that currently available studies do not provide enough supportive information to establish genes involved in metabolism for PBT risk assessment (Table 3 [71][72][73][74][75][76][77][78][79][80][81][82][83] ). Contradictory results were observed for MTHFR, MTRR, NAT2, and PON1 for glioma.…”
Section: Pbts Molecular Epidemiologic Studies With Focus On Metabolismmentioning
confidence: 99%
“…Our review indicated that currently available studies do not provide enough supportive information to establish genes involved in metabolism for PBT risk assessment (Table 3 [71][72][73][74][75][76][77][78][79][80][81][82][83] ). Contradictory results were observed for MTHFR, MTRR, NAT2, and PON1 for glioma.…”
Section: Pbts Molecular Epidemiologic Studies With Focus On Metabolismmentioning
confidence: 99%
“…Although the activities of these enzymes are assessed in some types The results of recent studies investigating the association between serum PON activity and various forms of cancer are highly variable. In a study conducted by Kafadar et al, serum PON1 activities of patients with high grade glioma and menegioma were significantly lower than controls (20). Similarly, Akçay et al reported decreased serum PON activities in patients with gastric and pancreatic cancers (10,11).…”
Section: Discussionmentioning
confidence: 95%
“…In studies evaluating the effect of PON1 192 genotyping on lipid levels, it has been reported that the PON1 192 gene polymorphism is not a major inhibitor in the oxidation of low-density lipoprotein, and for this reason, it may not affect lipid levels (Kafadar et al, 2006;Kucukali et al, 2008). In the present study, there was no significant difference in serum lipid 7 (29) 15 (63) 2 (8) 38 (79) 10 (21) Heterozygote and no mutation (N = 20) 4 (20) 11 (55) 5 (25) 30 (75) 10 (25) Control (N = 51)…”
Section: Discussionmentioning
confidence: 99%